Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06288503
NA

Hydrolysed Rice Formula Study

Sponsor: Nutricia UK Ltd

View on ClinicalTrials.gov

Summary

This non-inferiority study aims to determine whether a hydrolysed rice protein formula is as effective as a cow's milk protein based extensively hydrolysed formula using a double-blind, randomised-controlled design over a 28-day intervention period followed by a 2-month follow-up period in infants 0-13 months of age presenting with symptoms/clinical history suggestive of cow's milk allergy. The primary outcome is growth, and secondary outcomes are gastrointestinal tolerance, and differences in intake, allergic symptoms, parental QOL, acceptability, dietary intake, and safety.

Official title: A Double-blind, Randomised-controlled Trial Evaluating a Hydrolysed Rice Formula Compared to a Cow's Milk Protein-based Extensively Hydrolysed Formula in Infants with Cow's Milk Allergy

Key Details

Gender

All

Age Range

0 Months - 13 Months

Study Type

INTERVENTIONAL

Enrollment

86

Start Date

2024-02-01

Completion Date

2027-07

Last Updated

2025-02-26

Healthy Volunteers

No

Interventions

OTHER

Hydrolysed Rice Protein Formula

Infants randomised onto this arm will be taking the hydrolysed rice protein formula, with a minimum prescription of 30% of their energy requirements.

OTHER

Cow's Milk Based Extensively Hydrolysed Formula

Infants randomised onto this arm will be taking the control product, with a minimum prescription of 30% of their energy requirements.

Locations (2)

Gloucestershire Royal NHS Trust

Gloucester, Gloucestershire, United Kingdom

Bristol Royal Hospital for Children

Bristol, Somerset, United Kingdom